NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021

Citations Over TimeTop 1% of 2020 papers

Abstract

The NCCN Guidelines for Soft Tissue Sarcoma provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with soft tissue sarcomas. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including the development of a separate and distinct guideline for gastrointestinal stromal tumors (GISTs); reconception of the management of desmoid tumors; inclusion of further recommendations for the diagnosis and management of extremity/body wall, head/neck sarcomas, and retroperitoneal sarcomas; modification and addition of systemic therapy regimens for sarcoma subtypes; and revision of the principles of radiation therapy for soft tissue sarcomas.

Related Papers

• → Surgical and oncological outcomes after hindquarter amputation for pelvic sarcoma(2020)19 cited
• → Centralization of soft tissue sarcoma: Status in Sweden in 1982(1987)15 cited
• → Does Multidisciplinary Therapy at a Sarcoma Center Improve the Prognosis of Patients With Soft Tissue Sarcoma? A Retrospective Case Study at a Single Institute(2023)1 cited
• [Accomplishments of tumor surgery in soft tissue sarcoma in childhood].(1988)
• → Imaging Appearances of the Most Common Malignant and Benign Lesions from a Regional Soft Tissue Sarcoma Diagnostic Center(2023)